Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer
Paolo Tarantino(Harvard University), Sara M. Tolaney(Harvard University)
Cited by 0
Related Papers
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer
|npj Precision Oncology|2026|0